Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
David J Figueroa
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Yuan Liu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Robert C. Gagnon
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Keith C. Deen
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Christopher Carpenter
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Arundathy N. Bartlett-Pandite
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Paul De Souza
Consultant or Advisory Role - GlaxoSmithKline
Tom Powles
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Robert John Motzer
Consultant or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer